Showing results (141-150 of 162) with videos related to
Sort By:
Pageof 17
Cytometry. Part B, Clinical Cytometry|July 20, 2024
Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtainKatherine A Devitt, Wolfgang Kern, Malgorzata A Kajstura, et al.Circulation|March 17, 2004
Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathyColin J McMahon, Sherif F Nagueh, Ricardo H Pignatelli, et al.Proceedings of the National Academy of Sciences of the United States of America|November 4, 2021
Adhesion GPCR Latrophilin 3 regulates synaptic function of cone photoreceptors in a trans-synaptic mannerYuchen Wang, Yan Cao, Cassandra L Hays, et al.Gynecologic Oncology|August 5, 2020
Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatmentJung-Min Lee, Christina M Annunziata, John L Hays, et al.Cancer Research Communications|September 29, 2023
Marijuana and Cannabidiol Use Prevalence and Symptom Management Among Patients with CancerTheodore M Brasky, Alison M Newton, Sara Conroy, et al.Cancer Research|November 15, 2012
Definition of molecular determinants of prostate cancer cell bone extravasationSteven R Barthel, Danielle L Hays, Erika M Yazawa, et al.MMWR. Morbidity and Mortality Weekly Report|April 24, 2020
Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 - National Poison Data System, United States, January 1, 2020-March 31, 2020Arthur Chang, Amy H Schnall, Royal Law, et al.Future Oncology (London, England)|August 19, 2021
RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancerDavid M O'Malley, Leslie M Randall, Camille Gunderson Jackson, et al.Journal of the National Cancer Institute|May 21, 2014
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analysesJung-Min Lee, John L Hays, Christina M Annunziata, et al.Genetics|December 5, 2000
Extragenic suppressors of the nimX2(cdc2) mutation of Aspergillus nidulans affect nuclear division, septation and conidiationS L McGuire, D L Roe, B W Carter, et al.Pageof 17